The main objective of this study is to demonstrate the performance characteristics of the Magic Plate (MP) system when operated upstream of the patient in transmission mode (MPTM). The MPTM is an essential component of a real-time QA system designed for operation during radiotherapy treatment. Of particular interest is a quantitative study into the influence of the MP on the radiation beam quality at several field sizes and linear accelerator potential differences. The impact is measured through beam perturbation effects such as changes in the skin dose and/ or percentage depth dose (PDD) (both in and out of field). The MP was placed in the block tray of a Varian linac head operated at 6, 10 and 18 MV beam energy. To optimize the MPTM operational setup, two conditions were investigated and each setup was compared to the case where no MP is positioned in place (i.e., open field): (i) MPTM alone and (ii) MPTM with a thin passive contamination electron filter. The in-field and out-of-field surface doses of a solid water phantom were investigated for both setups using a Markus plane parallel (Model N23343) and Attix parallel-plate, MRI model 449 ionization chambers. In addition, the effect on the 2D dose distribution measured by the Delta 4 QA system was also investigated. The transmission factor for both of these MPTM setups in the central axis was also investigated using a Farmer ionization chamber (Model 2571A) and an Attix ionization chamber. Measurements were performed for different irradiation field sizes of 5 × 5 cm 2 and 10 × 10 cm 2 . The change in the surface dose relative to d max was measured to be less than 0.5% for the 6 MV, 10 MV, and 18 MV energy beams. Transmission factors measured for both set ups (i & ii above) with 6 MV, 10 MV, and 18 MV at a depth of d max and a depth of 10 cm were all within 1.6% of open field. The impact of both the bare MPTM and the MPTM with 1 mm buildup on 3D dose distribution in comparison to the open field investigated using the Delta 4 system and both the MPTM versions passed standard clinical gamma analysis criteria. Two MPTM operational setups were studied and presented in this article. The results indicate that both versions may be suitable for the new real-time megavoltage photon treatment delivery QA system under development. However, the bare MPTM appears to be slightly better suited of the two MP versions, as it minimally perturbs the radiation field and does not lead to any significant increase in skin dose to the patient. PACS number(s): 87.50.up, 87.53.Bn, 87.55.N, 87.55.Qr, 87.56.Fc. 
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I. INTRODUCTION
External photon beams such as intensity-modulated radiation therapy (IMRT) and, more recently, volumetric-modulated arc therapy (VMAT), which have highly conformal radiation delivery, have increasingly been applied for cancer treatment. (1, 2) The main goal of these techniques is to achieve dose distribution of increased conformity to the target volumes, while further reducing the doses to the healthy normal tissue. (3) VMAT consists of treating the patient by using one or more gantry arcs with continuously varying beam aperture shape, gantry speed, and dose rate. (4, 5) The complexity of IMRT and VMAT in treatment delivery places new demands on ensuring the quality of the linear accelerator dose delivery in real time, as its controller must now determine in real time the gantry position (VMAT), the multileaf collimator (MLC) operation, and jaw speed, as well as the dose rate (VMAT & IMRT). The complexity of the systems involved requires new and appropriate methods and potentially new tools in order to do this. Several devices dedicated to daily QA have been developed that can be used for IMRT and VMAT verification. (6) (7) (8) (9) (10) (11) (12) The 2D detector arrays based on ionization chambers play a major role in QA, but most of these are not suitable for in vivo 2D dose mapping. (10, (13) (14) (15) (16) (17) (18) 2D semiconductor based on diodes approaches, such as MapCHECK (Sun Nuclear Corp., Melbourne, FL) (5, 11, (19) (20) (21) and the quality control (QA) device, (22) have also been used for dose verification. Electronic portal imaging devices (EPIDs) have also been tested for in vivo dosimetry purposes. (12) In phantom, verification of the treatment plan in three dimensions (3D) can be carried out successfully using Delta 4 (Scandidos AB, Uppsala, Sweden), (23) ArcCHECK (Sun Nuclear Corp.), (5, (24) (25) (26) and Octavius (PTW, Freiburg, Germany). (27) There is considerable need for real-time in vivo verification of the IMRT and the VMAT that can be achieved by a transmission-type detector placed in the photon beam downstream of the MLC during treatment. The idea of a 2D array transmission detector for real-time in vivo QA in external beam radiation therapy (EBRT) was first proposed by Paliwal et al. (28) The transmission chamber was an off-the-shelf device called a Dose Area Product Meter (Gammex RMI, Inc., Middleton, WI) (28) using the concept of dose-area product to monitor the radiation beam in diagnostic applications for the measurement of patient exposure. The concept of a dose-area product was further developed to allow online in vivo comparison of measured dose-area product related to instantaneous MLC leaves opening and compare it with prerecorded data. (29, 30) Most of the currently used transmission-type detectors such as the COMPASS detector (IBA Dosimetry), (31) the integral quality monitoring system (IQM), (30) and the DAVID system (29, 32) are based on pixelated ionization chambers and these systems have been shown to significantly increase the patient surface dose due to additional electron contamination. The presence of these transmission devices also causes beam attenuation up to 7% for a 6 MV photon beam for doses beyond d max . (30, 31, 33) Recently, wireless transmission detectors, such as Delta 4 Discover (ScandiDos) based on a 2D diode array (34) and Dolphin (IBA Dosimetry) based on a 2D ionization chamber array, (35) have been introduced. These are very advanced in vivo QA dosimetry systems but clinical evaluation, and, in particular, their effect on skin dose and the perturbation of the radiation field still need to be evaluated. Although some of these QA delivery devices are available commercially, they are still rare in clinical practice for IMRT and VMAT delivery verification during patient daily treatment.
We are developing a solid-state-based detector system for real-time QA during radiotherapy treatment, which is completely independent of the known linear accelerator operating conditions. The 2D silicon transmission diode array, called the Magic Plate (MP) (36) is designed to be placed between the MLC and the patient, operating in transmission mode (MPTM). Therefore, the response of the 2D detector array can be correlated with the amount of 2D energy fluence incident on the patient and therefore with dose. Recently we have demonstrated possibility of 2D dose reconstruction at different depths in a phantom for different field configurations based on MPTM response. (37) The QA system will therefore provide immediate real-time feedback simultaneously with the patient treatment, leading to a very robust QA in treatment delivery.
The Magic Plate has been previously reported in dose mode (MPDM) to map a 2D dose distribution in a phantom. (36) However, for the real-time QA system, the MP is placed in the accessory slot on the head of the linac and must be operated as a transmission detector during the patient treatment with minimal perturbation of the incident radiation field, requiring a detailed study of its influence on the treatment beam. The surface dose in particular can be one of the limiting factors in treatment plans with high doses to a target and is the focus of this work. (38) Similar studies in the past have been completed for beam modifiers such as wedges, MLC, and block trays. (39) (40) (41) (42) Beam perturbation can be quantified by measuring changes in the percentage depth dose (PDD) profiles particularly in the buildup region, including surface dose, with the transmission MP placed in the beam. Ideally, such a device would have no significant impact on the treatment delivery, either to the target dose or surrounding normal tissues. Therefore, the main objective of this study is to quantitatively determine whether or not the presence of the MP upstream of the patient has a significant effect on the surface dose and PDD during patient treatment.
II. MATERIALS AND METHODS
The Magic Plate (MP) is a 2D detector array of 11 × 11 silicon epitaxial diodes covering an area of 10 × 10 cm 2 with a thickness of 0.45 mm, as shown in Fig. 1(a) . The physical size of a single epidiode is 1.5 × 1.5 × 0.425 mm 3 . The MP is designed to be operated in both transmission mode (MPTM) and dose mode (MPDM), and details of the MP design, preliminary characterization and the individual epitaxial silicon diodes utilized have been published elsewhere. (36, 43) For the MPTM investigation we examined two potential operational setup conditions:
(i) The MP array sandwiched between black plastic sheets, 80 μm thick, here in referred as "bare MPTM" as shown in Fig. 1(b) . The role of the black plastic is to remove light from the background detector response. (ii) The MP array with an additional 1 mm of solid water covering the entire array as shown in Fig. 1 (c). The role of the 1 mm solid water was to remove scattered low-energy electrons.
Condition (i) is designed for minimum attenuation of the primary linac beam; however, precise sampling of the energy fluence may be adversely affected by contamination electrons. To better sample the energy fluence the 1 mm of solid water was introduced in condition (ii) to filter a large component of these contamination electrons. The surface dose and percentage depth dose (PDD) for each setup (i.e., (i) and (ii) above) was measured and compared to the corresponding surface dose and PDD with no MP in place (i.e., open field). These measurements were carried out both in-field (on the beam central axis (CAX)) and out-of-field (OOF) for different field sizes.
Experiments were performed on two Varian linear accelerators (Model 2100EX), one of which operated at the energies of 6 MV and 10 MV, and another which was operated at 18 MV. Irradiation field sizes of 5 × 5 cm 2 and 10 × 10 cm 2 and a constant SSD of 100 cm were used for both linac experiments. Ionization chamber measurements were normalized to the maximum dose at a depth of 15 mm for 6 MV, 21 mm for 10 MV, and 30 mm for 18 MV beam energies. With the MPTM mounted on the linac accessory slot, PDD up to a depth of 10 cm were measured on the central axis (CAX) and out of the field (OOF) 11 cm laterally to CAX as a function of the irradiation field size. For the OOF measurements, the Solid Water phantom (Gammex RMI, Middleton, WI) and detector on the linac patient couch were moving laterally from the central axis position. The phantom size was 60 × 30 × 30 cm 3 with the lateral movement in the direction of the 60 cm phantom length to maintain consistent scattering conditions. The depth-dose profile and surface dose were measured with Markus type (PTW, Freiburg, Germany) parallel plate ionization chamber Model N23343. The chamber was connected via a tri-axial cable to a PTW UNIDOS model T10002-20713 electrometer with -300 V bias voltage applied. The Markus chamber is designed for the measurement of surface and buildup dose. Markus-type chambers are known for their overresponse due to the large separation and their small guard ring, (44, 45) and different methods have been developed to correct for this overresponse. (46) (47) (48) (49) In this study, all measurements using the Markus ionization chamber were corrected using the Velkley correction as modified by Rawlinson to correct the overresponse of the Markus chamber. The chamber dimension used for the correction calculation was obtained from Chen et al. (50) A dose of 200 MU was used for all measurements.
All measurements were performed with MPTM (source-to-detector distance (SDD) is 58 cm) for the two different setup conditions mentioned above and without MP (open field) as shown in Fig. 2 . All measurements were repeated at least three times in order to calculate the average value and standard deviation.
The depth dose as a function of field size in the solid water phantom were carried out using the Markus chamber mentioned above with some data compared with that using an Attix chamber (Gammex RMI), RMI model 449 for the same measurements. In the second part of this study, the influence of both the bare MPTM and the MPTM with 1 mm buildup on the open field 3D dose distribution (measured change as a percentage) was measured by the Delta 4 (Scandidos AB) QA system. Different treatment field configurations were used using the Delta 4 system positioned at isocenter for both MPTM versions to study Delta 4 response in comparison with open field. A 6 MV photon beam and different treatment configurations were used for both MPTM versions (bare MPTM and MPTM with 1 mm buildup). The center of the Delta 4 phantom was aligned at isocenter using the relevant markings on the PMMA. A daily correction factor (DCF) was applied to Delta 4 system measurements in order to account for differences in treatment conditions between the time of calibration and time of measurement. The DCF is calculated for a uniform, square field 20 × 20 cm 2 . The relevant DCF has been applied to all measurements. Prior to calculation of the DCF, the temperature is measured on the surface of the electrometer unit. The correction is calculated relative to the temperature at the time of absolute calibration. The temperature is input to the software and a correction is applied internally.
In the third part of this work, we investigated the transmission factor of the MP. The transmission factor was derived from any dose change measured at d max and at a depth of 10 cm for radiation field sizes 10 × 10 cm 2 and 5 × 5 cm 2 and an SSD of 100 cm for 6 MV, 10 MV, and 18 MV photon fields. A Farmer ionization chamber (Model 2571A) was used for 6 MV, 10 MV, and an Attix chamber, Model 449, was used for the 18 MV. Delta 4 system also was used to measure the transmission characteristics for 6 MV photon beam using different treatment configurations for both MP versions in comparison with the open field configuration. In the case of the OOF, the effect of the MPTM on radiation field perturbation is greater in terms of percentage change than for the equivalent CAX measurements. In addition, the majority of the change occurs within 10 mm below the phantom surface. With MPTM placed in the beam, the surface dose increased by 0.1076 cGy (1.4997%) for the 10 × 10 cm 2 and 0. 1051 cGy (6.2561%) 5 × 5 cm 2 field sizes, as shown in Figs. 3(b) and (d) . The equivalent using the MPTM with an additional 1 mm solid water buildup showed 0.8031 cGy (10.8580%) for 10 × 10 cm 2 and 0. 2914 cGy (16.9675%) for 5 × 5 cm 2 field sizes. Figure 4 shows the depth-dose profile of the 10 MV photon beam on the CAX and OOF for 10 × 10 cm 2 and 5 × 5 cm 2 field sizes with the bare MPTM (setup (i)) mounted in the linac accessory.
III. RESULTS
Similar to the 6 MV X-ray beam, the perturbation effect of the bare MPTM is small. The change in the surface dose by the introduction of the MPTM was a reduction of 0.3576 cGy (1.5604%) for 10 × 10 cm 2 and 0. 1097 cGy (0.7140%) for 5 × 5 cm 2 field sizes.
From Figs. 4(a) and (c) one can see that, for all depths investigated, the maximum measured change in absolute dose was less than -0.9138 cGy (-0.5778%) and -0.3045 cGy (-0.2322%) for the 10 × 10 cm 2 and 5 × 5 cm 2 field sizes, respectively. The greatest dose change occurs within 7 mm of the surface. The perturbation effect of MPTM on the depth-dose change in the CAX is less than 1% for all measured depths. A similar experiment with 1 mm solid water buildup placed above the MPTM showed an increase of the surface dose by +0.3280 cGy (+1.4345%) and +0.0552 cGy (+0.3576%) for 10 × 10 cm 2 and 5 × 5 cm 2 field sizes, respectively.
In OOF, the perturbation effect of the MPTM on depth-dose distribution is slightly higher than for the same dose in a CAX. Most dose change is within 10 mm from the surface. The surface dose with MPTM in the beam decreased slightly -0.0938 cGy (-1.2412%) for 10 cm × 10 cm 2 and increased +0.0702 cGy (+3.7167%) for the 5 × 5 cm 2 field sizes. The equivalent experiments using the MPTM with an additional 1 mm buildup showed an increase of the surface dose +0.5858 cGy (+7.5330%) and +0.3749 cGy (+20.2024%) for 10 × 10 cm 2 and 5 × 5 cm 2 field sizes, respectively. Figure 5 shows the depth-dose profile of an 18 MV photoneutron beam on the CAX and OOF for 10 × 10 cm 2 and 5 × 5 cm 2 field sizes with the bare MPTM (setup (i)) mounted in the linac accessory.
As for 6 MV and 10 MV X-ray beams, the perturbation effect of the bare MPTM is small. The change in the surface dose by the MPTM was -1.8991 cGy (-6.3814%) for 10 × 10 cm 2 and -0.8535 cGy (-6.2781%) for 5 × 5 cm 2 field sizes.
From Figs. 5(a) and (c) one can see that, for all depths investigated, the maximum measured change in absolute dose was less than +0.4773 cGy (+0.3013%) and +0.3947 cGy (+0.2025%) for the 10 × 10 cm 2 and 5 × 5 cm 2 field sizes, respectively. The most dose change occurs within 10 mm from the surface. The perturbation effect of MPTM on depth-dose change in the CAX is less than 1% for all measured depths. A similar experiment with 1 mm solid water buildup placed above the MPTM showed an increase of surface dose of -2.4356 cGy (-8.1842%) and -1.0862 cGy (-7.9895%) for 10 × 10 cm 2 and 5 × 5 cm 2 field sizes, respectively.
In OOF, the perturbation effect of the MPTM on depth-dose distribution is slightly higher than in a field. Most dose change is within 10 mm of the surface. The surface dose with MPTM in the beam slightly decreased by 0.3169 cGy (-3.4432%) for 10 × 10 cm 2 and decreased by 0. 04476 cGy (-1.9931%) for the 5 × 5 cm 2 field sizes. The equivalent experiments using the MPTM with additional 1 mm buildup showed a decrease in the surface dose of 0.1804 cGy (-1.9631%) and an increase of 0.08228 cGy (+3.6623%) for 10 × 10 cm 2 and 5 × 5 cm 2 field size, respectively. Table 1 summarizes the findings of the beam perturbation by MPTM at d max for all the above-presented radiation fields.
The quantitative absolute response (in nC per 100 MU) of the bare MPTM and the MPTM array with the additional 1 mm of solid water were measured for a 10 × 10 cm 2 and 5 × 5 cm 2 field sizes and beam energies of 6 MV, 10 MV, and 18 MV. The data are presented in Table 2 . As expected, 1 mm buildup is increasing the response of the diodes, however the signal is enough in both cases to reliably measure signal with accuracy better than 0.1% with developed 512 channel electrometer. Figure 6 shows the effect of having the MPTM system in place on the measured 2D dose mapping by the Delta 4 phantom diode array for a range of treatment field configurations. All data presented here are with the MP in transmission mode (the bare MPTM or MPTM with 1 mm buildup) with the data compared to the open field configuration with no MPTM in place. The measured changes in percent difference across the entire Delta 4 detectors have been displayed in Fig. 6 . In the case of the bare MPTM, the measured change in-field in percent difference (2 SDs) were ± 3.24%, ± 2.77%, ± 1.97%, ± 2.75%, and ± 2.72% for the 3 × 3 cm 2 , 5 × 5 cm 2 , 10 × 10 cm 2 , the beam segments, and modulated IMRT field configurations, respectively, for 6 MV photon beam. A similar experiment with 1 mm solid water buildup placed above the MPTM showed that the in-field measured change in percent difference (2 SDs) were ± 3.47%, ± 0.62%, ± 2.05%, ± 3.39%, and ± 3.10% for the 3 × 3 cm 2 , 5 × 5 cm 2 , 10 × 10 cm 2 , the beam segments, and modulated IMRT beam configurations, respectively, for 6 MV photon beam.
Gamma analysis was performed using 3% and 3 mm criteria. By comparing the planned dose to the delivered dose, a plan will fail the criteria if < 90% of all data points have a gamma index ≤ 1. Gamma analysis criteria (± 3% dose deviation, ≤ 3 mm distance to agreement and ≤ 1 gamma index) for both MPTM setups (i and ii) and open field for all configurations of delivered radiation fields was carried out based on comparison of 3D doses reconstructed by the Delta 4 system in comparison with 3D dose predicted by treatment planning system (TPS). The gamma index gave 100% (90%) pass criteria for all treatment configurations. Hence, this gamma threshold was not sensitive to the inclusion of the bare MPTM or MPTM with 1 mm buildup.
The transmission factor related to the dose change at d max and 10 cm depth in a solid water phantom for two field sizes (10 × 10 cm 2 and 5 × 5 cm 2 ) for 6 MV, 10 MV, and 18 MV energy beams were measured and are presented in Table 3 . Transmission factors at d max and a depth of 10 cm were all within 1.630% of open field. This increases the rigidity and potential lifetime reliability of the MP system. In the case of transmission detectors, both the IQM system and the DAVID system attenuate a 6 MV photon beam by 7%, while the COMPASS system reported a 3.3% beam attenuation, which are both greater than the values measured for the MP system. The recently introduced ScandiDos Delta4 Discover system attenuates the beam by up to 1%, (34) whereas no data have yet been reported for the IBA Dolphin detector.
The transmission characteristics for 6 MV photon beam using different treatment configurations for both MPTM versions in comparison with the open field configuration was measured by Delta 4 system at isocenter by finding difference in signals measured by all corresponding diodes in a field. In the case of the bare MPTM, the measured in-field transmission factors (2 SDs) were 0.9902 (± 3.24%), 0.9931 (± 2.76%), 0.9950 (± 1.96%), 0.9968 (± 2.74%), and 0.9984 (± 2.72%) for the 3 × 3 cm 2 , 5 × 5 cm 2 , 10 × 10 cm 2 , the beam segments, and modulated IMRT field configurations, respectively, for 6 MV photon beam. A similar experiment with 1 mm solid water buildup placed above the MPTM showed that the in-field measured transmission factors (2 SDs) were 0.9835 (± 3.46%), 0.9829 (± 0.62%), 0.9850 (± 2.04%), 0.9863 (± 3.38%), and 0.9873 (± 3.1%) for the 3 × 3 cm 2 , 5 × 5 cm 2 , 10 × 10 cm 2 , the beam segments, and modulated IMRT beam configurations, respectively, for 6 MV photon beam. These transmission characteristics measured are similar to those measured by an ionization chamber, as quoted in Table 3 .
IV. DISCUSSION
Two potential operational setup conditions of the MPTM were considered to investigate the perturbation of the radiation field, the first with a Magic Plate covered by a thin 80 μm layer of light protection plastic and the second with an additional 1 mm solid water buildup on top of the MPTM. The 1 mm solid water buildup was introduced to reduce the sensitivity of the MPTM response to contamination electrons from the source and scattered from the jaws, thus making correlation with the energy fluence less challenging.
Results suggest that for the majority of the radiation fields studied, the electrons produced from the interaction of the 6 MV and the 10 MV photons with the jaws are scattered. Most of these electrons are peaked forward and located close to the jaw surfaces, minimizing any contribution to the center of the 10 × 10 cm 2 field at the phantom surface. This is supported by the The Farmer ionization chamber was used for 6 MV and 10 MV and the Attix chamber was used for 18 MV.
increase in the relative surface dose when adding a 1 mm solid water slab above the MP which acts as a buildup for photons and an attenuator of scattered low-energy electrons. However, in the case of a 5 × 5 cm 2 field, the role of electrons scattered from the jaw to the center of the field is essential. This is supported by a small change in the relative surface dose caused by the addition of the 1 mm slab above the MP. This effect is a combination of the attenuation of the low-energy electrons scattered from the jaws and the generation of electrons from direct photon interactions within the 1 mm solid water buildup. It was demonstrated that the OOF surface dose enhancement produced by a 1 mm buildup was greater than when the bare MPTM was used. This result is consistent with the CAX measurements and supports the radiation field perturbation interpretations on the CAX. The CAX and OOF dose with depth with the bare MPTM (Figs. 3 to 5 ) in place shows that the MPTM has negligible effect otherwise for all investigated fields and photon energies. The depth-dose distribution perturbation is less than 1% at any depth, less than 10 cm in solid water. Perturbation factors at d max and at a depth of 10 cm were found to be less than 1.63% of the open field for all energies tested. The MPTM therefore produces very minimal distortion of the field and skin dose, both in field and OOF. Monte Carlo simulations are required for detailed explanation of the observed dose reduction and enhancement due to the MPTM which will form part of future work.
V. CONCLUSIONS
The impact of the black plastic sheet and the 1 mm of solid water on the changes in the skin dose and full PDD have been investigated. The results showed that in general, both versions of the MPTM detector array could potentially be used as a 2D transmission detector. However, if the surface dose considered as an important factor to be considered for the cancer treatment, then the bare MPTM proved to be the best candidate as the increase to the surface dose was the least of the two systems tested.
The design of the MP (detectors and packaging) has been shown to be suitable for mounting the full QA device in the linac accessory slot during patient radiotherapy treatment. We have demonstrated that at 6 MV, 10 MV, and 18 MV the MPTM in the beam minimally perturbs the radiation field both in a field and out of field, leading to a < 0.5% increase in dose at the surface relative to dose at d max and < 1% in depth of the phantom. This change is minimal and within any dosimetry budgeted error, while potentially allowing for real-time verification of VMAT and IMRT during patient treatment. Further work will be directed to the conversion of the response of MPTM directly to the absorbed dose in a patient without using the beam model. 
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